Biochemistry assistant professor and Morgridge Institute for Research investigator Jason Cantor was recently granted a prestigious award from the American Cancer Society to continue his investigation into conditionally essential genes in human cancer cells. Utilizing CRISPR, a revolutionary DNA-editing technology, Cantor and his team will make large-scale screens to possibly identify what genes are essential for the survival and growth of human cells.
“Many thanks to the American Cancer Society for supporting our work that will investigate conditionally essential genes in human cancer cells – it is truly an honor for me to once again be part of the ACS family,” Cantor says. “We are very much looking forward to making many impactful contributions to the fight against cancer and to sharing our work and goals with the local community for many years to come!”
Cantor’s work has the potential to contribute to cancer therapies, as the proteins encoded by each gene could be promising drug targets in certain cancers.
By Morgan Lock. This news originally appeared on the Morgridge Institute for Research website.